Increased expression of Ob-Rb and its relationship with the overexpression of TGF-β1 and the stage of fibrosis in patients with nonalcoholic steatohepatitis

被引:42
作者
Cayon, A. [1 ]
Crespo, Javier [1 ]
Mayorga, M. [1 ]
Guerra, A. [1 ]
Pons-Romero, F. [1 ]
机构
[1] Univ Hosp Marques Valdecilla, Gastroenterol & Hepatol Unit, Sch Med, E-39008 Santander, Spain
关键词
leptin; leptin-receptor; NASH; nonalcoholic steatohepatitis; Ob-Rb; TGF-beta;
D O I
10.1111/j.1478-3231.2006.01337.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aims: The main aim of this study was to examine the relationship of the leptin system in steatosis and nonalcoholic steatohepatitis (NASH). The study also analysed the pathogenic role of the leptin system in the development of hepatic fibrosis and its relation with the TGF-beta 1 system. Materials and methods: The study included 90 subjects, 55 with NASH and 35 with simple steatosis. Gene expression of leptin, leptin receptor and TGF-beta mRNA was analysed by real-time PCR on liver tissue. Leptin serum levels were determined by RIA. Leptin receptor expression was also assessed by immunohistochemistry. Results: Increased expression was found for leptin receptor mRNA (P=0.0016) and its protein (P < 0.05) in patients with NASH, especially those with fibrosis. There was a marked increase in gene expression of TGF-beta 1 in patients with NASH (P=0.0002). A strong correlation was demonstrated between leptin receptor gene expression and TGF-beta 1 gene expression (P=0.023). No leptin expression was found in the liver tissue. All patients showed a marked hyperleptinemia, which was closely related to the anthropometric characteristics analysed and independent of development or not of NASH. Conclusions: The results of the study demonstrate for the first time increased leptin receptor expression in liver tissue and its relationship with overexpression of TGF-beta 1 and the degree of hepatic fibrosis.
引用
收藏
页码:1065 / 1071
页数:7
相关论文
共 22 条
[1]   Transforming growth factor β and the liver [J].
Bissell, DM ;
Roulot, D ;
George, J .
HEPATOLOGY, 2001, 34 (05) :859-867
[2]   Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions [J].
Brunt, EM ;
Janney, CG ;
Di Bisceglie, AM ;
Neuschwander-Tetri, BA ;
Bacon, BR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2467-2474
[3]  
Chalasani N, 2003, AM J GASTROENTEROL, V98, P2771, DOI [10.1016/j.amjgastroenterol.2003.09.037, 10.1111/j.1572-0241.2003.08767.x]
[4]   Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity? [J].
Chitturi, S ;
Farrell, G ;
Frost, L ;
Kriketos, A ;
Lin, R ;
Liddle, C ;
Samarasinghe, D ;
George, J .
HEPATOLOGY, 2002, 36 (02) :403-409
[5]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[6]   Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295
[7]   Plasma leptin and TNF-α levels in chronic hepatitis C patients and their relationship to hepatic fibrosis [J].
Crespo, J ;
Rivero, M ;
Fábrega, E ;
Cayón, A ;
Amado, JA ;
García-Unzeta, MT ;
Pons-Romero, F .
DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (07) :1604-1610
[8]  
Garcia-Suarez C, 2004, Gastroenterol Hepatol, V27, P47, DOI 10.1157/13056425
[9]   Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal [J].
Henriksen, JH ;
Holst, JJ ;
Moller, S ;
Brinch, K ;
Bendtsen, F .
HEPATOLOGY, 1999, 29 (06) :1818-1824
[10]   In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy [J].
Hickman, IJ ;
Powell, EE ;
Prins, JB ;
Clouston, AD ;
Ash, S ;
Purdie, DM ;
Jonsson, JR .
JOURNAL OF HEPATOLOGY, 2003, 39 (06) :1042-1048